Zacks Investment Research on MSN

Ocugen stock surges 75% year to date: What's in store for 2026?

Ocugen OCGN is making rapid progress in its gene therapy programs for retinal diseases, which have differentiated mechanisms ...

Spin-engineered copper nanozyme enables efficient lignin conversion and strong green adhesives

Lignin is the most abundant renewable aromatic polymer in nature. Its conversion into high value-added chemicals or materials ...

CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...